| Literature DB >> 26503033 |
Siri Ranlund1, Rick A Adams1,2, Álvaro Díez1, Miguel Constante3, Anirban Dutt4, Mei-Hua Hall5, Amparo Maestro Carbayo4, Colm McDonald6, Sabrina Petrella4,7, Katja Schulze8, Madiha Shaikh4,9, Muriel Walshe1,4, Karl Friston10, Dimitris Pinotsis10, Elvira Bramon1,2,4.
Abstract
The mismatch negativity (MMN) evoked potential, a preattentive brain response to a discriminable change in auditory stimulation, is significantly reduced in psychosis. Glutamatergic theories of psychosis propose that hypofunction of NMDA receptors (on pyramidal cells and inhibitory interneurons) causes a loss of synaptic gain control. We measured changes in neuronal effective connectivity underlying the MMN using dynamic causal modeling (DCM), where the gain (excitability) of superficial pyramidal cells is explicitly parameterised. EEG data were obtained during a MMN task--for 24 patients with psychosis, 25 of their first-degree unaffected relatives, and 35 controls--and DCM was used to estimate the excitability (modeled as self-inhibition) of (source-specific) superficial pyramidal populations. The MMN sources, based on previous research, included primary and secondary auditory cortices, and the right inferior frontal gyrus. Both patients with psychosis and unaffected relatives (to a lesser degree) showed increased excitability in right inferior frontal gyrus across task conditions, compared to controls. Furthermore, in the same region, both patients and their relatives showed a reversal of the normal response to deviant stimuli; that is, a decrease in excitability in comparison to standard conditions. Our results suggest that psychosis and genetic risk for the illness are associated with both context-dependent (condition-specific) and context-independent abnormalities of the excitability of superficial pyramidal cell populations in the MMN paradigm. These abnormalities could relate to NMDA receptor hypofunction on both pyramidal cells and inhibitory interneurons, and appear to be linked to the genetic aetiology of the illness, thereby constituting potential endophenotypes for psychosis.Entities:
Keywords: DCM; NMDA receptor; cortical excitability; cortical gain; dynamic causal modeling; effective connectivity; genetic risk; psychosis; schizophrenia; unaffected relatives
Mesh:
Year: 2015 PMID: 26503033 PMCID: PMC4843949 DOI: 10.1002/hbm.23035
Source DB: PubMed Journal: Hum Brain Mapp ISSN: 1065-9471 Impact factor: 5.038
Sample demographics (N = 84)
| Patients with psychosis | Unaffected relatives | Controls | |
|---|---|---|---|
| Mean age (years, SD) | 34.6 (±9.3) | 43.7 (±14.5) | 41.8 (±14.5) |
| Age range (years) | 23–54 | 16–62 | 19–69 |
| Gender ( | 18/6 (25%) | 12/13 (52%) | 17/18 (51%) |
| Education (mean years, SD) | 13.6 (±2.8) | 14.0 (±3.1) | 14.4 (±3.7) |
| Diagnosis ( | |||
| Schizophrenia | 18 (75%) | – | – |
| Schizoaffective disorder | 3 (13%) | – | – |
| Psychosis NOS | 1 (4%) | – | – |
| Bipolar I disorder (w. psychosis) | 2 (8%) | – | – |
| Major Depression | – | 3 (12%) | 1 (3%) |
| No psychiatric illness | – | 22 (88%) | 34 (97%) |
| Illness duration (mean years, SD) | 12.1 (8.4) | NA | NA |
| Psychotropic medication ( | 23 (95.8%) | NA | NA |
| CPZ equivalent (mean, min‐max)* | 549.4 (30‐1100) | NA | NA |
| Years medicated (mean, SD) | 10.6 (±8.6) | NA | NA |
| First medicated (mean years, SD) | 24.4 (±7.2) | NA | NA |
| PANSS (mean, SD)** | |||
| Positive | 12.5 (±4.6) | 7.2 (±0.6) | 7.0 (±0.0) |
| Negative | 14.9 (±5.5) | 7.2 (±0.6) | 7.0 (±0.0) |
| General | 24.3 (±4.9) | 17.5 (±2.0) | 16.1 (±0.4) |
| Relationship to proband ( | |||
| Mother | NA | 4 (16.0%) | NA |
| Father | NA | 9 (36.0%) | NA |
| Sister | NA | 8 (32.0%) | NA |
| Brother | NA | 3 (12.0%) | NA |
| Daughter | NA | 1 (4.0%) | NA |
NA = not applicable; SD = standard deviation; NOS = not otherwise specified; * CPZ equivalent = average chlorpromazine equivalent dosage (mg) for those taking antipsychotic medication (N = 18); ** PANSS positive and negative scores range from 7 to 49, PANSS general scores range from 16 to 112
Figure 1Image showing (A) the prior source locations (overlaid on an MRI image of a standard brain) and (B) the structural model used for dynamic causal modeling. The sources are linked by extrinsic (forward, backward, and lateral) connections, and each source has intrinsic inhibitory self‐connections. A1 = primary auditory cortex; STG = superior temporal gyrus; IFG = inferior frontal gyrus; l = left hemisphere; r = right hemisphere. [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 2Dynamic causal modeling model space; identifying group differences in intrinsic (self‐inhibitory) connectivity. Red arrows indicate a modulated connection. A1 = primary auditory cortex; STG = superior temporal gyrus; IFG = inferior frontal gyrus; l = left hemisphere; r = right hemisphere. [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 3EEG activity to standard and deviant tones for each group (grand averages across subjects), at channel FZ. [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 4(A) Bayesian model selection results investigating intrinsic (inhibitory) modulations at different levels of the hierarchy. Log model evidences relative to the null model are shown. The winning model has modulations at A1 and IFG, and the difference in log evidence between this and the runner‐up is 80. (B) Changes in intrinsic connectivity strengths under the winning model, at each source, for patients, relatives and controls, and for standard (std.) and deviant (dev.) trials. A1 = primary auditory cortex; STG = superior temporal gyrus; IFG = inferior frontal gyrus; l = left hemisphere; r = right hemisphere. [Color figure can be viewed in the online issue, which is available at http://wileyonlinelibrary.com.]
Figure 5Posterior estimates of the (log scaling of) intrinsic connection parameters and their 95% confidence intervals, for each source and experimental effects investigated. A1 = primary auditory cortex; IFG = inferior frontal gyrus.